Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes

Sarah A Hitchen, Nick S R Lan, James M Rankin, Robert Larbalestier, Bu B Yeap, P Gerry Fegan

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science